Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06325150 · ClinicalTrials.gov registry record · Phase 1
The Impact of Light Exposure on Cognitive Function in Classrooms
A Phase 1 study, sponsored by Michigan State University.
- Not yet
- Registry status
- Phase 1
- Development phase
- 300
- Enrollment target
NCT06325150: Clinical Trial Phase 1 study, sponsored by Michigan State University.
NCT06325150 is a Phase 1 study that has not yet begun recruiting, run by Michigan State University. The registered enrollment target is 300 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (400% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06325150, a Phase 1 study, has not yet begun recruiting, sponsored by Michigan State University.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 300 participants
- Enrollment target
Study Summary
Humans are constantly exposed to a variety of light types, created naturally or through artificial means. Light exposure captured by the eyes impacts many physiological functions in humans, including but not limited to cognitive output, fatigue levels, and mood regulation. The level of impact on cognitive learning from different types of light on undergraduate adult students remains unclear.
Primary Outcome
To measure the impact of the intervention on attention, for each student we will measure the time it takes for the student to complete the provided test, and the number of errors in the test. Each student will completed the test, before and after the intervention, and the change in test score (time and errors) calculated.
Interventions
- DEVICE Light emitting glasses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-05-16 |
| Est. Completion | 2028-02-01 |
| Phase | Phase 1 |
What is known before NCT06325150 opens enrollment
NCT06325150 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (400% higher).
The record links to 0 conditions, and to 1 intervention - of which Light emitting glasses is the first listed.
NCT06325150 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06325150 about?
NCT06325150 is a clinical study titled "The Impact of Light Exposure on Cognitive Function in Classrooms". Humans are constantly exposed to a variety of light types, created naturally or through artificial means. Light exposure captured by the eyes impacts many physiological functions in humans, including but not limited to cognitive output, fatigue levels, and mood regulation. The level of impact on cog...
What is the current status of trial NCT06325150?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 300 participants. The study started on 2026-05-16. Estimated completion is 2028-02-01.
What interventions are being tested in trial NCT06325150?
The interventions under investigation include: Light emitting glasses (DEVICE).
Who is sponsoring clinical trial NCT06325150?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06325150's enrollment target sits among peer trials
300 124th of 2000 higher than 1,867 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI